INBRACE Trademark

Trademark Overview

On Friday, November 18, 2016, a trademark application was filed for INBRACE with the United States Patent and Trademark Office. The USPTO has given the INBRACE trademark a serial number of 87241956. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, September 5, 2024. This trademark is owned by Neurocrine Biosciences, Inc.. The INBRACE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information regarding pharmaceutical products and services; Pharmaceutical consultation, namely, treatment support programs that coordinate insurance, drug delivery and prescription management between physicians, patients, and pharmacies
inbrace

General Information

Serial Number87241956
Word MarkINBRACE
Filing DateFriday, November 18, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, September 5, 2024
Registration Number5424430
Registration DateTuesday, March 13, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Pseudo MarkIN BRACE
Goods and ServicesProviding medical information regarding pharmaceutical products and services; Pharmaceutical consultation, namely, treatment support programs that coordinate insurance, drug delivery and prescription management between physicians, patients, and pharmacies

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 26, 2016
Primary Code044
First Use Anywhere DateThursday, April 13, 2017
First Use In Commerce DateThursday, April 13, 2017

Trademark Owner History

Party NameNeurocrine Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Thursday, March 16, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 22, 2016NEW APPLICATION ENTERED
Saturday, November 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 29, 2016NOTICE OF PSEUDO MARK E-MAILED
Friday, February 24, 2017ASSIGNED TO EXAMINER
Friday, February 24, 2017NON-FINAL ACTION WRITTEN
Friday, February 24, 2017NON-FINAL ACTION E-MAILED
Friday, February 24, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 16, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, December 20, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, March 16, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, March 16, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, March 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 23, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 23, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 20, 2017USE AMENDMENT FILED
Tuesday, January 9, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 9, 2018STATEMENT OF USE PROCESSING COMPLETE
Saturday, February 3, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 6, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 13, 2018REGISTERED-PRINCIPAL REGISTER
Monday, March 13, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 16, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, February 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 5, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 5, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 5, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

inbrace pharmaceutical prescription delivery drug insurance management between pharmacies patients physicians